1 April 2025

Swissmedic: Expansion of the Swissmedic position paper on real world evidence

Swissmedic has updated its position paper on the use of real world evidence (RWE). The document now includes an annex providing an overview of relevant international guidelines and publications to reflect the current situation in science and technology.

For more information, see here and here.

More News

21 October 2026
FOPH: Poison Information Centre: Government seeks to secure long-term Funding through Legislation
20 October 2026
Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products
16 October 2026
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
16 October 2026
Swissmedic: The new Pharmacopoea Helvetica 13
14 October 2026
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
13 October 2026
Decision C-6534/2024 of 13 October 2026
13 October 2026
Swissmedic: Haemovigilance Annual Report 2025
9 October 2026
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
8 October 2026
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
1 October 2026
European Medicines Agency: Highlights of the September 2026 Management Board meeting

lifesciencelaw.ch

Swissmedic: Expansion of the Swissmedic position paper on real world evidence

More News

FOPH: Poison Information Centre: Government seeks to secure long-term Funding through Legislation

Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products

European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes

Swissmedic: The new Pharmacopoea Helvetica 13

FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient

Decision C-6534/2024 of 13 October 2026

Swissmedic: Haemovigilance Annual Report 2025

Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues

European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent

European Medicines Agency: Highlights of the September 2026 Management Board meeting

We use cookies